Personally, I quite like the idea of a phase I dose escalation study evaluating the effectiveness of Bisantrene as an FTO inhibitor in multiple advanced cancers in the US. I also like the idea of it being in collaboration with City of Hope, but that may not eventuate. Regardless of where and who with, a trial like that would take $$ - at the time of the announcement, the phase I dose escalation study idea was being explored and was not "committed" to like other programs mentioned.
Ann: Trading Halt, page-46
-
- There are more pages in this discussion • 323 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
